Department of Medicine, Weill Cornell Medicine, Doha, Qatar.
Department of Medicine, Weill Cornell Medicine, New York, USA.
Clin Obes. 2021 Apr;11(2):e12434. doi: 10.1111/cob.12434. Epub 2020 Dec 26.
The prevalence and incidence of obesity, and associated complications, such as type 2 diabetes, in the Middle East and north Africa (MENA) region rank among the highest in the world. Little is known about the effectiveness of dietary weight loss interventions conducted in the MENA region. We conducted a systematic review of randomized clinical trials aiming to assess the effectiveness of dietary interventions for weight loss in the adult population originating from and residing in the MENA region. In accordance with PRISMA guidelines, PubMed, CINAHL, Cochrane, and EMBASE were systematically searched for randomized controlled trials (RCT) using dietary interventions for weight loss conducted in the MENA region. RCTs examining weight loss as an outcome in adults (≥ 18 years old) were included. The Cochrane Collaboration tool for assessing risk of bias was used to ascertain the quality of the eligible RCTs and the Template for Intervention Description and Replication for population health and policy interventions (TIDieR-PHP) checklist was used to evaluate the reporting of the interventions. Twenty-nine RCTs including 2792 adults from five countries in the MENA region met the search criteria. Study participants were predominantly middle-aged females. Duration of follow up was mostly 3 months or less. Weight loss ranged from -0.7 to 16 kg across all intervention groups and the average weight loss was 4.8 kg. There was paucity of description of the weight loss interventions and variations amongst studies did not allow a meta-analysis of findings. It was not possible to draw firm conclusions on the effectiveness of dietary weight loss interventions in the region. High quality studies using more structured interventions of longer duration with standardized outcome measures are needed in the MENA region to support clinical practice with evidence-based interventions for obesity.
在中东和北非(MENA)地区,肥胖的流行率和发病率以及与之相关的并发症(如 2 型糖尿病)位居世界前列。关于在该地区进行的饮食减肥干预措施的有效性知之甚少。我们对旨在评估针对来自和居住在 MENA 地区的成年人群进行的饮食干预措施减肥效果的随机临床试验进行了系统回顾。根据 PRISMA 指南,系统地在 PubMed、CINAHL、Cochrane 和 EMBASE 中搜索了针对 MENA 地区进行的饮食干预减肥的随机对照试验(RCT)。纳入了将体重减轻作为成年人(≥18 岁)结局进行检查的 RCT。使用 Cochrane 协作风险偏倚评估工具来确定合格 RCT 的质量,并使用人群健康和政策干预措施描述和复制模板(TIDieR-PHP)清单来评估干预措施的报告。来自 MENA 地区五个国家的 29 项 RCT 包括 2792 名成年人,符合搜索标准。研究参与者主要是中年女性。随访时间大多为 3 个月或更短。所有干预组的体重减轻范围为-0.7 至 16kg,平均体重减轻 4.8kg。对减肥干预措施的描述很少,并且研究之间的差异使得无法对研究结果进行荟萃分析。因此,无法就该地区饮食减肥干预措施的有效性得出明确结论。MENA 地区需要使用更结构化的干预措施、更长的持续时间和标准化的结果测量来进行高质量的研究,以支持基于证据的肥胖干预措施的临床实践。